Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Treatment Response to Exposure Therapy Using a CO2 Habituation Paradigm in Patients With High Levels of Anxiety Sensitivity

NCT03925987 is registered in ClinicalTrials.gov with Laureate Institute for Brain Research, Inc. as lead sponsor.

NCT NCT03925987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03925987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Treatment Response to Exposure Therapy Using a CO2 Habituation Paradigm in Patients With High Levels of Anxiety Sensitivity
Lead sponsor
Laureate Institute for Brain Research, Inc.
Phase
Not applicable
Overall status
Completed
Start date
June 7, 2018
Completion date
July 31, 2020
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

agoraphobia, generalized anxiety disorder, panic disorder, social anxiety disorder